Kyndryl Holdings, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the quarterly period ended September 30, 2026.

Key Highlights

  • Quarterly revenue: $3,651 million for the three months ended September 30, 2026, compared with $3,721 million in the same period of the prior year, according to the filing.
  • Net income: $59 million for the three months ended September 30, 2026, versus $68 million in the prior-year quarter, the filing reported.
  • Diluted earnings per share: $0.27 for the three-month period, compared with $0.29 in the prior-year quarter, as stated in the consolidated income statement.
  • Six-month net income: $4 million for the six months ended September 30, 2026, down from $124 million in the same period of the prior year, per the filing.
  • Cash and cash equivalents: $1,659 million at September 30, 2026, compared with $2,623 million at March 31, 2026, according to the consolidated balance sheet.
  • Total assets: $11,866 million at September 30, 2026, versus $12,551 million at March 31, 2026, as disclosed in the filing.
  • Shares outstanding: 217,828,178 shares of common stock outstanding as of October 28, 2026, the filing stated.

Kyndryl Financial Results for the Quarter Ended September 30, 2026

Kyndryl Holdings, Inc. (NYSE:KD) reported quarterly revenues of $3,651 million for the three months ended September 30, 2026, a decrease from $3,721 million in the three months ended September 30, 2025, according to the unaudited consolidated income statement included in the filing. Total costs and expenses for the quarter were $3,539 million, compared with $3,622 million in the prior-year quarter. Income before income taxes was $112 million, with a provision for income taxes of $53 million, resulting in net income of $59 million. Weighted-average diluted shares outstanding were 219.1 million for the quarter.

For the six months ended September 30, 2026, the filing disclosed revenues of $7,269 million versus $7,464 million in the comparable prior-year period. Six-month total costs and expenses were $7,226 million, including workforce rebalancing charges of $190 million and impairment expense of $38 million, both of which the filing identified as line items for the six-month period. Net income for the six-month period was $4 million, compared with $124 million in the same period of the prior year. Basic earnings per share for the six months were $0.02, versus $0.54 in the prior-year period.

On the balance sheet at September 30, 2026, the filing reported total liabilities of $10,689 million and total equity of $1,176 million. Long-term debt stood at $3,281 million, up from $2,293 million at March 31, 2026. Treasury stock at cost was $699 million, reflecting 30.8 million shares, compared with $582 million and 21.7 million shares at March 31, 2026. The accumulated deficit was $(1,865) million at September 30, 2026, compared with $(1,869) million at March 31, 2026. Total comprehensive income (loss) for the six-month period was $(24) million, the filing stated.

What Was Disclosed

Kyndryl filed an unaudited quarterly report covering the three and six months ended September 30, 2026, disclosing revenue, net income, earnings per share, balance sheet positions, and share counts for the period, with comparisons to the prior fiscal year.